PASADENA, Calif.–(BUSINESS WIRE)–Deep 6 AI, a synthetic intelligence (AI) firm targeted on accelerating affected person recruitment for scientific trials, as we speak introduced the addition of Jason Attanucci as Vice President of Life Sciences to the rising Deep 6 AI management workforce. On this newly created function, Jason will introduce the Deep 6 AI Medical Trials Acceleration Software program (CTAS) platform to the life sciences eClinical market.
“Deep 6 AI is primed for speedy progress within the life sciences eClinical market – and all the scientific trial ecosystem at giant,” mentioned Jason. “Deep 6’s means to precision-match sufferers to scientific trials, utilizing AI and pure language processing is unparalleled within the trade. I’m thrilled to supply this distinctive data-driven answer that connects all scientific trial stakeholders, in assist of our mission to assist convey new therapies to sufferers, quicker.”
Jason brings almost 20 years of profitable life science management to Deep 6 AI. Most lately, Jason served as World Head of Buyer Options and Sr. Director of Gross sales and Partnerships at BioFortis, a scientific analysis know-how options supplier. Earlier expertise consists of world and nationwide management positions at Bioclinica, Medidata Options, and GenoLogics Life Sciences Software program Inc.
Jason holds a B.S. in each microbiology and molecular biology from the College of Pittsburgh, and studied Immunology at College of Pittsburgh College of Drugs.
“Jason is a good addition to our management workforce.” mentioned Wout Brusselaers, CEO of Deep 6 AI. “His deep understanding of the eClinical market and singular concentrate on worth supply for our purchasers will assist convey the advantages of Deep 6 AI’s cutting-edge software program answer to biopharmaceutical sponsors and contract analysis organizations world wide.”
ABOUT DEEP 6 AI
Utilizing synthetic intelligence on medical information, Deep 6 AI finds extra, better-matching sufferers for scientific trials in minutes, not months, getting life-saving cures to sufferers extra shortly. Its software program connects analysis groups, care workers, sufferers, and sponsors, throughout a quickly rising real-world knowledge ecosystem of premier analysis organizations, akin to Cedars-Sinai Medical Middle and Rutgers Well being. Deep 6 AI helps sponsors and CROs with higher trial design, feasibility, website choice, affected person accruals, real-time evaluation of examine outcomes, and improved trial response charges. Deep 6 AI is a Techstars and StartX alum. The corporate was based in 2016 and relies in Pasadena, CA. Study extra at https://deep6.ai.